President Donald Trump once again showed off the “Art of the Deal” with his announcement of another huge deal he’s made with some of the top pharmaceutical manufacturers, to bring a present to Americans ahead of Christmas, with Most Favored Nation Pricing (MFN).
Speaking from the Oval Office, Trump said that he has been able to negotiate with nine manufacturers— Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis, and Sanofi—to offer lower prescription drug costs on some of the medications for chronic conditions, diabetes, asthma, and even cancer.
As President Trump put it simply, whatever the lowest price for a medication is in the world, Americans will now get that, something that we didn’t have under former President Joe Biden.
.@POTUS: "As of today, 14 out of the 17 largest pharmaceutical companies have now agreed to drastically lower drug prices for their American patients... This represent the greatest victory for patient affordability in the history of American healthcare by far." pic.twitter.com/k8O6WlzG31
— Rapid Response 47 (@RapidResponse47) December 19, 2025
READ MORE: Trump Administration Announcing Deal on Lowering Cost, Access on Fertility Treatments, IVF
MORE: New: Trump Announces Second Big Deal on Drug Pricing for Americans
“As of today, 14 out of the 17 largest pharmaceutical companies, but they’ve all agreed, have now agreed to drastically lower drug prices for their American patients, for the American people and patients. This represent the greatest victory for patient affordability in the history of American healthcare by far."
“And every single American will benefit. So, this is the biggest thing ever to happen on drug pricing and on healthcare,” he added. “This will have a tremendous impact on healthcare itself.”
Trump then provided an example of some of those “massive price reductions Americans will see as a result of the agreements made with pharmaceutical manufacturers.”
A White House press release provided some of those details.
- Amgen will reduce the price of its cholesterol-lowering drug Repatha from $573 to $239 for patients purchasing directly through TrumpRx.
- Boehringer Ingelheim will reduce the price of its type two diabetes medication, Jentadeuto, from $525 to $55 for patients purchasing directly through TrumpRx.
- Genentech will reduce the price of its flu medication, Xofluza, from $168 to $50 for patients purchasing directly through TrumpRx.
- GSK will reduce the prices of its inhaler portfolio. Prices for the popular asthma inhaler Advair Diskus 500/50 will fall from $265 to $89 for patients purchasing directly through TrumpRx.
- Merck will reduce the price of its diabetes medication, Januvia, from $330 to $100 for patients purchasing directly through TrumpRx.
- Sanofi will reduce the price of its prescription blood thinner, Plavix, from $756 to $16 for patients purchasing directly through TrumpRx, and Sanofi will list its insulin products at TrumpRx at $35 per month’s supply.
WATCH: @POTUS lists some of the massive price reductions Americans will see as a result of the agreements made with pharmaceutical manufacturers:
— Rapid Response 47 (@RapidResponse47) December 19, 2025
"Sanofi will cut the cost of its blood thinner... from $750 to less than $16." https://t.co/7Yu8XWfA2e pic.twitter.com/VuXQhnOCP0
At one point, Secretary of Health and Human Services Robert F. Kennedy Jr. shared Trump’s deal with pharma manufacturers has even impressed his son, whom he called a “very, very, left-wing Democrat.” He said his son pointed out that it was the thing he heard promises for from the likes of former President Barack Obama, President Joe Biden, and Sen. Bernie Sanders (I-VT), but they never delivered.
.@SecKennedy on @POTUS' major new deals to lower drug prices for Americans: "NOBODY has done anything for affordability greater than this." https://t.co/7Yu8XWfA2e pic.twitter.com/g1ceo55UTv
— Rapid Response 47 (@RapidResponse47) December 19, 2025
“He called me, and he said, ‘Dad. I want to tell you how proud I am about this. This is the best achievement that could happen to our country.’"
"I would say this is a miracle. Nobody had done anything for affordability greater than this,” Sec. Kennedy added.
Sec. Kennedy then credited the president with what he called his “relentless harassment of us to make sure this all got done.”
The release noted that this agreement will also provide every “State Medicaid program in the country access to MFN drug prices on products made by the nine companies, resulting in billions of dollars in savings and continuing President Trump’s historic efforts to strengthen the program for the most vulnerable.”
So much winning! What a great present for the American people.
Editor's Note: President Trump is leading America into the "Golden Age" as Democrats try desperately to stop it.
Please help us continue to report on President Trump's successes. Join RedState VIP and use promo code MERRY74 to receive 74% off your membership.
Join the conversation as a VIP Member